Susquehanna International Group, LLP Myovant Sciences Ltd. Call Options Transaction History

Susquehanna International Group, LLP

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	SELL	$24.03 - $27.02 $180,225 - $202,650	-7,500 Reduced 4.59%	155,900 $4.2 Million
Q3 2022 Nov 14, 2022	SELL	$11.6 - $20.44 $1.11 Million - $1.96 Million	-96,100 Reduced 37.03%	163,400 $2.94 Million
Q2 2022 Aug 15, 2022	BUY	$7.78 - $14.69 $861,246 - $1.63 Million	110,700 Added 74.4%	259,500 $3.23 Million
Q1 2022 May 16, 2022	BUY	$11.38 - $16.4 $19,346 - $27,879	1,700 Added 1.16%	148,800 $1.98 Million
Q4 2021 Feb 14, 2022	SELL	$14.31 - $23.87 $794,205 - $1.32 Million	-55,500 Reduced 27.39%	147,100 $2.29 Million
Q3 2021 Nov 15, 2021	BUY	$18.94 - $26.99 $223,492 - $318,482	11,800 Added 6.18%	202,600 $4.55 Million
Q2 2021 Aug 11, 2021	BUY	$17.07 - $24.56 $2.07 Million - $2.97 Million	121,100 Added 173.74%	190,800 $4.35 Million
Q1 2021 May 17, 2021	SELL	$20.46 - $25.18 $343,728 - $423,024	-16,800 Reduced 19.42%	69,700 $1.43 Million
Q4 2020 Feb 16, 2021	BUY	$13.8 - $27.62 $931,500 - $1.86 Million	67,500 Added 355.26%	86,500 $2.39 Million
Q3 2020 Nov 16, 2020	BUY	$14.05 - $22.6 $37,935 - $61,020	2,700 Added 16.56%	19,000 $267,000
Q2 2020 Aug 14, 2020	SELL	$7.34 - $20.84 $342,778 - $973,228	-46,700 Reduced 74.13%	16,300 $336,000
Q4 2019 Feb 14, 2020	BUY	$4.2 - $19.21 $264,600 - $1.21 Million	63,000 New	63,000 $978,000

61.3K

Ticker MYOV
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 96,802,800
Description
Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.